CF PHARMTECH (02652) spent approximately 532,900 Hong Kong dollars to repurchase 15,000 shares on January 28th.
Changfeng Pharmaceutical (02652) announced that on January 28, 2026, it spent approximately 532,900 Hong Kong dollars to repurchase 15,000 shares.
CF PHARMTECH (02652) announced that on January 28, 2026, it spent about HK$532,900 to buy back 15,000 shares.
Related Articles
B.DUCK SEMK (02250) intends to discount approximately 9.76% to sell 67.568 million shares, raising approximately 49.5 million Hong Kong dollars.
Due to the investigation of money laundering involving employees, Deutsche Bank (DB.US) reacted before the market opened and fell sharply.
Jiahe Bioscience (06998) spent 2.4095 million Hong Kong dollars on repurchasing 973,500 shares on January 28th.
B.DUCK SEMK (02250) intends to discount approximately 9.76% to sell 67.568 million shares, raising approximately 49.5 million Hong Kong dollars.
Due to the investigation of money laundering involving employees, Deutsche Bank (DB.US) reacted before the market opened and fell sharply.
Jiahe Bioscience (06998) spent 2.4095 million Hong Kong dollars on repurchasing 973,500 shares on January 28th.
RECOMMEND
New Record Achieved As Spot Gold Tops $5,000 For The First Time; Institutions Set $6,600 Target
27/01/2026
117 Companies Raised Over HKD 285.6 Billion Through IPOs As Hong Kong Reclaims Global Leadership In 2025
27/01/2026
“A+H Hong Kong Listing Requires RMB 30 Billion Market Cap”? On‑Site Inquiry Dispels The Rumor
27/01/2026
